The effect of BayK 8644 on cytosolic Ca^(2+) concentrations ([Ca^(2+)](subscript i)) and viability in PC3 human prostate cancer cells was explored. Fura-2 was applied to measure [Ca^(2+)](subscript i). BayK 8644 at 1-50 μM induced a [Ca^(2+)](subscript i) rise concentration-dependently. The response was reduced by removing extracellular Ca^(2+). BayK 8644-evoked Ca^(2+) entry was inhibited by nifedipine, econazole, SK&F96365, and protein kinase C modulators. In Ca^(2+)-free medium, incubation with the endoplasmic reticulum Ca^(2+) pump inhibitor 2, 5-di-tert-butylhydroquinone (BHQ) abolished BayK 8644-induced [Ca^(2+)](subscript i) rise. Inhibition of phospholipase C did not alter BayK 8644-induced [Ca^(2+)](subscript i) rise. BayK 8644 killed cells in a concentration-dependent manner, which was not reversed by chelating cytosolic Ca^(2+) with 1, 2-bis (2-aminophenoxy) ethane-N, N, N', N'-tetraacetic acid/acetoxy methyl (BAPTA/AM). Collectively, in PC3 human prostate cancer cells, BayK 8644 induced a [Ca^(2+)](subscript i) rise by evoking phospholipase C-independent Ca^(2+) release from the endoplasmic reticulum and Ca^(2+) entry via protein kinase C-sensitive store-operated Ca^(2+) channels (and/or T-type Ca^(2+) channels). At high concentrations, BayK 8644 caused cell death.